Alannah Smrke

30 papers receiving 509 citations

Hit Papers

Future Directions in the Treatment of Osteosarcoma2021202620222024202150100150

Peers

Alannah Smrke
Comparison fields: 5 of 81
  • Oncology 238
  • Pulmonary and Respiratory Medicine 160
  • Molecular Biology 117
  • Public Health, Environmental and Occupational Health 101
  • Cancer Research 62
Replace Hyewon Ryu with:
Hyewon Ryu South Korea
Mustafa Oktay Tarhan Türkiye
Hye Jung Chang South Korea
Roberto Montera Italy
Satoshi Yamaguchi Japan
Gary Crouch United States
Spyridon Gennatas United Kingdom
Mutlu Doğan Türkiye
Kiran H. Lagisetty United States
S. Tashiro Japan
Alannah Smrke relative to Hyewon Ryu South Korea Hyewon Ryu's profile →
Citations per field
00.5×1.5×
Hyewon Ryu · 1×
Citations per year

Countries citing papers authored by Alannah Smrke

Since Specialization
Citations

This map shows the geographic impact of Alannah Smrke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alannah Smrke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alannah Smrke more than expected).

Fields of papers citing papers by Alannah Smrke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alannah Smrke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alannah Smrke. The network helps show where Alannah Smrke may publish in the future.

Co-authorship network of co-authors of Alannah Smrke

This figure shows the co-authorship network connecting the top 25 collaborators of Alannah Smrke. A scholar is included among the top collaborators of Alannah Smrke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alannah Smrke. Alannah Smrke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 1
4 3
5 1
6 7
7 0
8 5
9 13
10 7
11 4
12 1
13 4
14
Future Directions in the Treatment of Osteosarcomabreakdown →
160
15 24
16 19
17 2
18 46
19 19
20 16

About Alannah Smrke

Alannah Smrke is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 516 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (14 papers), Cardiac tumors and thrombi (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (238 citations), Pulmonary and Respiratory Medicine (160 citations) and Cancer Research (62 citations). Alannah Smrke has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Robin L. Jones, Spyridon Gennatas, Paul H. Huang, Peter M. Anderson, Ashish Gulia, Charlotte Benson, Christine Simmons, Eve Merry, Olga Husson and Sheima Farag. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026